(19)
(11) EP 1 579 008 A1

(12)

(43) Date of publication:
28.09.2005 Bulletin 2005/39

(21) Application number: 03808491.9

(22) Date of filing: 19.12.2003
(51) International Patent Classification (IPC)7: C12Q 1/68
(86) International application number:
PCT/US2003/040551
(87) International publication number:
WO 2004/057034 (08.07.2004 Gazette 2004/28)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 19.12.2002 US 435257 P

(71) Applicant: Source Precision Medicine, Inc.
Boulder, CO 80301 (US)

(72) Inventors:
  • BEVILACQUA, Michael
    Boulder, CO 80301 (US)
  • TRYON, Victor
    Loveland, CO 80537 (US)
  • CHERONIS, John, C.
    Conifer, CO 80433 (US)
  • BANKAITIS-DAVIS, Danute M.
    Longmont, CO 80503 (US)

(74) Representative: Jones, Helen M.M. 
Gill Jennings & Every, Broadgate House, 7 Eldon Street
London EC2M 7LH
London EC2M 7LH (GB)

   


(54) IDENTIFICATION, MONITORING AND TREATMENT OF INFECTIOUS DISEASE AND CHARACTERIZATION OF INFLAMMATORY CONDITIONS RELATED TO INFECTIOUS DISEASE USING GENE EXPRESSION PROFILES